UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma

Frontiers in oncology, 2017-05, Vol.7, p.87-87

2017

Volltextzugriff (PDF)

YAP activation is an early event and a potential therapeutic target in liver cancer development

Journal of hepatology, 2014-11, Vol.61 (5), p.1088-1096

2014

Volltextzugriff (PDF)

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD

International journal of molecular sciences, 2021-12, Vol.22 (23), p.13105

2021

Volltextzugriff (PDF)

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)

Hepatology (Baltimore, Md.), 2014-01, Vol.59 (1), p.228-241

2014

Volltextzugriff (PDF)

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis

Oncotarget, 2016-05, Vol.7 (22), p.32375-32393

2016

Volltextzugriff (PDF)

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma

Cancers, 2020-11, Vol.12 (11), p.3318

2020

Volltextzugriff (PDF)

Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10452

2023

Volltextzugriff (PDF)

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma

iScience, 2023-12, Vol.26 (12), p.108363-108363, Article 108363

2023

Volltextzugriff (PDF)

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

Frontiers in oncology, 2023-02, Vol.13, p.1127517-1127517

2023

Volltextzugriff (PDF)

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis

Cancers, 2020-08, Vol.12 (8), p.2305

2020

Volltextzugriff (PDF)

Induction of autophagy promotes the growth of early preneoplastic rat liver nodules

Oncotarget, 2016-02, Vol.7 (5), p.5788-5799

2016

Volltextzugriff (PDF)

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma

Frontiers in oncology, 2022-09, Vol.12, p.941552-941552

2022

Volltextzugriff (PDF)

The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis

Frontiers in immunology, 2022-10, Vol.13, p.1007647-1007647

2022

Volltextzugriff (PDF)

Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model

Journal of hepatology, 2022-07, Vol.77, p.S732

2022

Volltextzugriff (PDF)

Nrf2, but not [beta]-catenin, mutation represents an early event in rat hepatocarcinogenesis

Hepatology (Baltimore, Md.), 2015-09, Vol.62 (3), p.851

2015

Volltextzugriff (PDF)

GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease

Gene expression, 2017-11, Vol.17 (4), p.265-275

2017

Volltextzugriff (PDF)

Diverse MicroRNAs‐mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia

Cell proliferation, 2022-04, Vol.55 (4), p.e13199-n/a

2022

Volltextzugriff (PDF)

Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis

Hepatology (Baltimore, Md.), 2015-09, Vol.62 (3), p.851-862

2015

Volltextzugriff (PDF)

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

Journal of hepatology, 2020-06, Vol.72 (6), p.1159-1169

2020

Volltextzugriff (PDF)

The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models

Journal of the peripheral nervous system, 2023-03, Vol.28 (1), p.98-107

2023

Volltextzugriff (PDF)

Potential role of two novel agonists of thyroid hormone receptor-beta on liver regeneration

Journal of hepatology, 2020-08, Vol.73, p.S249

2020

Volltextzugriff (PDF)

THU220 - Potential role of two novel agonists of thyroid hormone receptor-beta on liver regeneration

Journal of hepatology, 2020-08, Vol.73, p.S249-S249

2020

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis

European journal of medicinal chemistry, 2020-02, Vol.188, p.112006, Article 112006

2020

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(34)
Male
(21)
Humans
(19)
Animals
(18)
Female
(13)
Rats
(10)
Rats, Inbred F344
(10)
Oncology
(9)
Gastroenterology & Hepatology
(7)
Hepatocytes - Metabolism
(7)
Infant
(7)
Liver
(7)
Cancer
(6)
Cell Biology
(6)
Gene Expression
(6)
Hcc
(6)
Infant Nutritional Physiological Phenomena
(6)
Metabolism
(6)
Middle Aged
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma

YAP activation is an early event and a potential therapeutic target in liver cancer development

TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD

Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)

Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection

Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis

Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma

Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma

Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis

Induction of autophagy promotes the growth of early preneoplastic rat liver nodules

mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma

The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis

Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model

Nrf2, but not [beta]-catenin, mutation represents an early event in rat hepatocarcinogenesis

GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease

Diverse MicroRNAs‐mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia

Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models

Potential role of two novel agonists of thyroid hormone receptor-beta on liver regeneration

THU220 - Potential role of two novel agonists of thyroid hormone receptor-beta on liver regeneration

Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis

Suchergebnisse filtern